Quick Overview for SensoLyte® 520 Factor Xa Assay Kit (ABIN1882459)
抗原
See all Factor Xa (FXa) 试剂盒检测方法
应用范围
-
-
品牌
- SensoLyte®
-
产品特性
- The SensoLyte® 520 Factor Xa Assay Kit provides a convenient assay for high throughput screening of FXa inhibitors or continuous assay of enzyme activity. It detects FXa activity using a 5-FAM/QXL™ 520 fluorescence resonance energy transfer (FRET) peptide. In the intact FRET peptide, the fluorescence of 5-FAM is quenched by QXL™ 520. Upon cleavage into two separate fragments by FXa, the fluorescence of 5-FAM is recovered, and can be monitored at excitation/emission wavelengths = 490 nm/520 nm. With excellent fluorescence quantum yield and longer wavelength, 5-FAM shows less interference from autofluorescence of test compounds and cellular components. The assays are performed in a convenient 96-well microplate format.
-
-
Activated Coagulation Factor X (FXa) ELISA Kit
FXa 适用: 大鼠 Colorimetric Competition ELISA 15.6 pg/mL - 1000 pg/mL Plasma, Serum, Tissue Homogenate
Activated Coagulation Factor X (FXa) ELISA KitFXa 适用: 人 Colorimetric Sandwich ELISA 0.312 ng/mL - 20 ng/mL Plasma, Serum, Tissue Homogenate
SensoLyte® Rh110 Factor Xa Assay KitFRET Fluorometric
-
-
说明
-
FRET-based Assay Kit
-
限制
- 仅限研究用
-
-
-
注意事项
- Protect Components A and B from light and moisture.
-
储存条件
- -80 °C
-
储存方法
- Store all kit components at -20 °C, except for Component C. Store Component C at -80 °C. Component D can be stored at room temperature for convenience
-
-
- Factor Xa (FXa) (Activated Coagulation Factor X (FXa))
-
别名
- Factor Xa
-
背景
- Factor Xa (FXa) is a serine endopeptidase composed of two disulfide-linked subunits. FXa leads to blood clot formation by converting prothrombin to thrombin through the prothrombinase complex. FXa is generated from zymogen Factor X via the intrinsic and extrinsic pathways and is the rate-limiting step in the propagation of thrombin generation. In the presence of Ca2+ ions, FXa forms prothrombinase with factor Va on the phospholipid membrane of the activated platelets. FXa has emerged as an attractive target for drug discovery for thromboembolic diseases.
抗原
-
